Implementation and outcome of personalized treatment strategies in advanced genitourinary cancers
For a majority of GU cancer patients an MMT was identified and responses were seen in heavily pretreated patients. Additional controlled trials and integration of comprehensive molecular analyses and subsequent personalized therapy should be considered for patients with GU cancers, especially those with rare histologies.
Authors
- Damian Tobias Rieke (ORCID: https://orcid.org/0000-0003-0027-7977)
- Thorsten Schlomm (ORCID: https://orcid.org/0000-0001-9557-4653)
- R. Tahbaz
- Wolfgang Schmitt (ORCID: https://orcid.org/0000-0002-7870-138X)
- Marieke Joosten (ORCID: https://orcid.org/0000-0002-4443-4690)
- Markus Möbs (ORCID: https://orcid.org/0000-0002-1502-3032)
- Ulrich Bernd Keller (ORCID: https://orcid.org/0000-0002-8485-1958)
- Sebastian Ochsenreither (ORCID: https://orcid.org/0000-0001-6024-4312)
- Barbara Erber
- T. Kim
- Ivan Jelas (ORCID: https://orcid.org/0000-0001-8969-6080)
- Dieter Beule (ORCID: https://orcid.org/0000-0002-3284-0632)
- Ulrich Keilholz (ORCID: https://orcid.org/0000-0001-6773-9406)
- Arne Klostermann
- Maren Knödler (ORCID: https://orcid.org/0000-0001-7475-6829)
- Nadine Biernath
- Limin Chai (ORCID: https://orcid.org/0000-0002-9207-1169)
- Manuela Benary (ORCID: https://orcid.org/0000-0002-3067-2030)
- Yvette Jegodka
- Maria De Santis (ORCID: https://orcid.org/0000-0003-4969-0877)
- T. Debertshäuser
Institutions
- German Cancer Society (DE)
- Berlin Institute of Health at Charité - Universitätsmedizin Berlin (DE)
- Franklin University (US)
- Medical University of Vienna (AT)
- Charité - Universitätsmedizin Berlin (DE)
Publication Details
- Journal
- ESMO Open
- Published
- 2025-07-01
- DOI
- https://doi.org/10.1016/j.esmoop.2025.105497
- Citations
- 1
- Primary Topic
- Prostate Cancer Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 1.52